Related Experiment Video
Updated: Sep 4, 2025

06:08
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
365
Granulomatous Prostatitis Mimicking Invasive Prostate Cancer
Romain Gillard1, Laurent Médart1, Amélie Parisel1
1CHR Liège, BE.
Journal of the Belgian Society of Radiology
|July 21, 2022
Summary
Benign granulomatous prostatitis can appear like prostate cancer on MRI scans. A patient's specific urological history, like prior Bacillus Calmette-Guérin treatment, is key to distinguishing between these conditions.
Area of Science:
- Urology
- Radiology
- Pathology
Background:
- Prostate cancer is a common malignancy requiring accurate diagnosis via MRI.
- Benign granulomatous prostatitis (BGP) can present with imaging findings that overlap with prostate cancer.
- Distinguishing BGP from prostate cancer on MRI is crucial for appropriate patient management.
Observation:
- A specific patient case highlights the diagnostic challenge of BGP mimicking prostate cancer on MRI.
- The patient's history included topical Bacillus Calmette-Guérin (BCG) instillations, a known factor in granulomatous inflammation of the prostate.
Findings:
- Granulomatous inflammation in the prostate, often associated with BCG therapy, can lead to imaging features indistinguishable from malignancy on MRI.
- MRI findings in BGP may include peripheral zone abnormalities, diffusion restriction, and contrast enhancement patterns similar to prostate cancer.
Implications:
- Thorough patient urological history, particularly regarding BCG treatment, is essential for interpreting prostate MRI findings.
- Integrating clinical history with imaging allows for accurate differentiation between benign inflammatory conditions and prostate cancer, avoiding unnecessary biopsies or treatments.
- This highlights the importance of a multidisciplinary approach in prostate cancer diagnosis and management.

